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Abstract 21 
Peptidomics is a necessary alternative in the analysis of naturally generated peptides in 22 
dry-fermented processing. The intense proteolysis occurred during the processing of 23 
dry-fermented sausages is due to the action of endopeptidases and exopeptidases from 24 
both, endogenous muscle origin and lactic acid bacteria (LAB) added in the starter. 25 
Sodium caseinate is frequently used as an additive in this type of products because of its 26 
emulsifying properties, and consequently influences the protein profile available during 27 
the proteolysis. In this study, a mass spectrometry approach has been used to determine 28 
the impact of added sodium caseinate in the final peptide profile as well as to analyse its 29 
possible influence in the presence of certain previously described casein-derived 30 
bioactive peptides. 31 
 32 
 33 
 34 
 35 
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Introduction 42 
A number of reactions responsible for the characteristic texture, flavour, and odour take 43 
place during the processing of dry-fermented sausages. Key reactions are lipid 44 
hydrolysis and autoxidation, proteolysis, and transformation of amino acids to aromatic 45 
compounds. In this sense, although endogenous enzymes are main responsible for the 46 
intense proteolysis that takes place during dry-fermented processing, the action of 47 
microorganisms such as lactic acid bacteria has been proved to mainly influence the last 48 
period of fermentation, also contributing to the generation of small peptides and free 49 
amino acids (Toldrá and Flores, 2011). Frequently, additives such as sodium caseinate 50 
are added into dry-fermented products as an ingredient of the formulation because of 51 
their emulsifying properties. These added proteins also suffer similar transformations to 52 
endogenous meat proteins, being also a source of small peptides and free amino acids. 53 
These peptides, in addition to contribute to the development of the characteristic flavour 54 
of dry-fermented products, have been described to exert important bioactive functions 55 
such as antioxidant and antihypertensive activity in dry-cured meat products (Escudero 56 
et al., 2013; and Mora et al., 2013).  57 
During the last decade, the most common strategy used to study protein changes and to 58 
identify, and quantitatively characterize, the proteomic profile of a complex mixture is 59 
based on the isolation of proteins by using two dimensional SDS-PAGE electrophoresis 60 
separations and the digestion with specific peptidases such as trypsin to be analyzed by 61 
mass spectrometry (MS), what is commonly named Peptide Mass Fingerprint (PMF) 62 
approach. However, when the aim of the study is to identify and sequence naturally 63 
released peptides, this strategy commonly used in proteomics is not possible, and the 64 
use of MS in tandem is necessary.  65 
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Main difficulties in the study of naturally generated peptides arises from both, the small 66 
size of these fragments that cannot be trypsin digested and sometimes are in the limit of 67 
some mass spectrometry techniques, and the impossibility of controlling the hydrolysis, 68 
obtaining a complex mixture of peptides from different proteins with unspecific 69 
cleavage sites. For this reason, the use of advanced proteomic techniques such as mass 70 
spectrometry in tandem is essential to elucidate the sequence of these small peptides. 71 
Thus, recent advances in proteomics constitute an indispensable tool to develop fast, 72 
precise and sensitive analysis of released peptides in complex biological samples like 73 
dry-fermented products (López et al., 2015).  74 
In this work, a peptidomic approach using a quadrupole/time-of-flight (Q/ToF) mass 75 
spectrometer has been used to study the influence of the addition of sodium caseinate in 76 
the final peptide profile of dry-fermented sausages. 77 
Material and methods 78 
Chemical and reagents 79 
The chemical trifluoroacetic acid (TFA), was purchased from Sigma-Aldrich (St. Louis, 80 
MO, USA). Acetonitrile HPLC grade and formic acid were from Scharlab (Barcelona, 81 
Spain). For the MALDI-ToF/ToF analysis, α-Cyano-4-hydroxycinnamic acid from 82 
Sigma-Aldrich (St. Louis, MO, USA) was used as matrix, and Peptide Mass Standards 83 
kit for Calibration of AB SCIEX MALDI TOF Instruments (MA, USA) was also 84 
provided. All other reagents were of analytical grade. 85 
Spanish dry-fermented sausages 86 
Dry-fermented sausages were prepared by using a 75% of lean pork and a 25% of pork 87 
back fat. Additives such as NaCl at a concentration of 27 g/kg, lactose at 20 g/kg, 88 
dextrin at 20 g/kg and sodium caseinate at 20 g/kg were added, as well as glucose (7 89 
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g/kg), sodium ascorbate (0.5 g/kg), sodium nitrite (0.15 g/kg), and potassium nitrate 90 
(0.15 g/kg). Dry-fermented sausages were inoculated with a starter culture C-P-77S 91 
bactoferm (Chr. Inc., Hansen, Denmark) containing Lactobacillus pentosus and 92 
Staphylococcus carnosus. Ripening process was developed in two steps at 75-85% of 93 
humidity that were 22 hours at 15-20ºC, followed by 43 days at 9ºC. 94 
Peptide extraction 95 
A total of 50 g of dry-fermented sausages made of pork were minced after the removal 96 
of fat, and homogenised with 200 mL of 0.01 N HCl for 8 min in cold. The homogenate 97 
was centrifuged (12,000 g for 20 min at 4 ° C), the supernatant was filtered through 98 
glass wool, and then deproteinized by adding three volumes of ethanol and maintaining 99 
the sample overnight at 4°C. Then, sample was centrifuged again (12,000g for 20 min at 100 
4°C) and the supernatant was freeze-dried. Finally, the dried extract was dissolved in 25 101 
mL of 0.01 N HCl and filtered through a 0.45 m nylon membrane filter (Millipore, 102 
Bedford, MA, USA) until use. 103 
Peptide-mass mapping by MALDI-ToF MS 104 
Matrix-assisted laser desorption/ionization time-of-flight mass spectromety was used to 105 
determine the molecular mass of the peptides contained in the extract. The analysis was 106 
performed using a 5800 MALDI-TOF/TOF (AB Sciex, MA, USA) in positive reflectron 107 
mode (3000 shots every position) in a range from 200 to 3500 Da; the laser intensity 108 
was manually adjusted to maximize the s/n ratio. Spectra were obtained from 3000 109 
shots in every position with a final laser intensity of 3500. Plate model and acquisition 110 
method were calibrated by AB Sciex calibration mixture (des-Arg1-Bradykinin at 1 111 
fmol/μL; Angiotensin I at 2 fmol/μL; Glu1-Fibrinopeptide B at 1.3 fmol/μL; ACTH (1–112 
17 clip) at 2  fmol/μL; ACTH (18–39 clip) at 5 fmol/μL; and ACTH (7–38 clip) at 3 113 
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fmol/μL) in 13 positions. Dry-fermented sausage extract was diluted ten times in H2O-114 
ACN (95:5) with 0.1% TFA, and 1 L was spotted on 10 positions in the MALDI plate 115 
and allowed to air dry. Once dried, 0.5 L of matrix solution (5 mg/mL of α-Cyano-4-116 
hydroxycinnamic acid in H2O-ACN (30:70) with 0.1% TFA was spotted.  117 
The spectra obtained by MALDI-TOF MS were analysed using mMass - Open Source 118 
Mass Spectrometry Tool software v5.5  (Strohalm et al., 2010; Niedermeyer and 119 
Strohalm, 2012). 120 
Nano-LC-MS/MS analysis 121 
The nanoLC-MS/MS analysis was performed using an Eksigent Nano-LC Ultra 1D Plus 122 
system (Eksigent of AB Sciex, CA, USA) coupled to a quadrupole-time-of-flight (Q-123 
ToF) TripleTOF® 5600+ system from AB Sciex Instruments (Framingham, MA, USA) 124 
that is equipped with a nanoelectrospray ionization source. 125 
A dilution of ten times of the dry-fermented sausages extract was done and five 126 
microlitres of the supernatant were injected into the LC-MS system through the 127 
autosampler. Samples were then preconcentrated on an Eksigent C18 trap column (3, 128 
350m x 0.5mm) (Eksigent of AB Sciex, CA, USA), at a flow rate of 3 µL/min and 129 
using 0.1% v/v TFA as mobile phase. After 5 min of preconcentration, the trap column 130 
was automatically switched in-line onto a nano-HPLC capillary column (3µm, 75µm x 131 
12.3 cm, C18) (Nikkyo Technos Co, Ltd. Japan). The mobile phases consisted of 132 
solvent A, containing 0.1% v/v formic acid (FA) in water, and solvent B, containing 133 
0.1% v/v FA in 100% acetonitrile. Chromatographic conditions were a linear gradient 134 
from 5% to 35% of solvent B over 90 min, and 10 min from 35% to 65% of solvent B, 135 
at a flow rate of 0.3 μL/min and running temperature of 30 ºC. 136 
The outlet of the capillary column was directly coupled to a nano-electrospray 137 
ionisation system (nano-ESI). The Q/ToF was operated in positive polarity and 138 
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information-dependent acquisition mode, in which a 0.25-s ToF MS scan from m/z of 139 
100 to 1200 was performed, followed by 0.05-s product ion scans from m/z of 100 to 140 
1500 on the 50 most intense 1 to 5 charged ions.  141 
Results and discussion 142 
In this study, MALDI-ToF mass spectrometry has been used to determine the amount 143 
and molecular masses of the peptides naturally generated during the dry-fermented 144 
processing. This information results very useful in the optimization of the conditions in 145 
the nLC-MS/MS analysis. Under controlled conditions of digestion, in silico strategy 146 
resulted in an economically accessible and fast way to know the theoretical size and 147 
sequence of the peptides generated from known proteins.  However, when peptides have 148 
been generated by the action of endogenous enzymes and/or microorganisms, MALDI-149 
ToF becomes a necessary alternative to determine the peptide profile. Figure 1 shows 150 
the MALDI ToF spectra from 200 to 900 m/z (A) and from 850 to 3500 m/z (B), 151 
indicating that there is an extensive distribution of peptides in a wide range of molecular 152 
masses. 153 
An extraction of the naturally generated peptides in dry-fermented sausages (at 43 days 154 
of processing) has been done and the resulting extract was analysed using nanoLC-155 
MS/MS in order to identify the sequences of the peptides generated by the action of 156 
muscle enzymes and microorganisms as well as their proteins of origin. In this respect, 157 
a total of 347 proteins have been identified with a confidence higher than 95%. All these 158 
proteins were of muscle origin except casein, which was added as an ingredient during 159 
the preparation of dry-fermented sausages because of its emulsifying characteristics. 160 
From the total amount of peptides identified, the four types of casein proteins represent 161 
the 16% just beyond titin protein (31%), a giant cytoskeletal protein of vertebrate 162 
striated muscle with a molecular weight of 3MDa (see Figure 2).  163 
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Thus, an intense proteolysis occurred during the dry-fermented processing releasing a 164 
large amount of peptides. The obtained results are similar to those observed in other 165 
type of dry-cured meat products of 10 and 14 months of curing (Escudero et al, 2013; 166 
and Mora et al, 2013). So a possible explanation for the very intense proteolysis 167 
occurred in the 43 days of processing of dry-fermented sausages described in this study 168 
could be due to the combined action of LAB and endogenous enzymes.  169 
Table 1 shows a brief description of the results obtained by nanoLC-MS/MS. -casein, 170 
-S1- and -S2-casein and -casein were identified with a sequence coverage of 94, 80, 171 
69, and 71 %, respectively, indicating the high availability of this protein for the 172 
endogenous muscular enzymes and microorganisms action (see Figure 3). This fact is 173 
probably due to muscle proteins which are joined within the structure forming the 174 
muscle tissue which makes them less available for the proteolytic action, increasing the 175 
chance for added casein protein to be hydrolyzed.  176 
In this study, parameters of the nLC-MS/MS analysis were adjusted for the 177 
identification of peptides comprised from 6 to 50 residues. The highest number of 178 
peptides have been identified from -casein protein with a total of 603 peptides that 179 
represents a ratio (number of peptides identified vs total number of residues in the 180 
sequence) of 2.69, very high in comparison to ratios 1.27, 0.66, and 0.64 from -S1- 181 
and -S2-casein and -casein, respectively. Lactic acid bacteria such as Lactobacillus 182 
pentosus and Staphylococcus carnosus used in this study have a very complex 183 
proteolytic system that consisted on a proteinase attached to the cell wall that supports 184 
the extracellular casein degradation into oligopeptides (Darewicz et al., 2006). These 185 
oligopeptides are moved into the cytoplasm and finally degraded into smaller molecules 186 
and amino acids by intracellular peptidases (Chaves-López et al., 2014; Liu et al., 187 
2010). On the other hand, endogenous enzymes can be divided into endopeptidases, 188 
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responsible for the degradation of muscle into protein fragments and polypeptides, and 189 
endopeptidases, that acts on these fragments and are main responsible for the generation 190 
of small peptides and free amino acids.  191 
Figure 4 shows the percentage distribution of amino acids in the protein sequences of 192 
the four types of caseins. Pro, Leu and Val are the most abundant amino acids of -193 
casein in comparison with the other types of caseins, whereas Leu and Glu are main 194 
amino acids of 1-casein, Lys and Glu in 2-casein, and Pro and Ala in -casein. The 195 
generation of this high level of peptides is due to aminopeptidase and carboxypeptidase 196 
activities from either endogenous enzymes (Aristoy and Toldrá, 1995; Toldrá and 197 
Flores, 1998; Lametsch et al., 2003) or acid lactic bacteria added in the starter 198 
(Herreroset al., 2003, Bintsis et al., 2003; Macedo et al., 2010). A possible reason for 199 
the higher number of peptides identified from -casein in comparison with the other 200 
types of casein (see Table 2 and 3) could be the preference of aminopeptidases and 201 
carboxypeptidases for Pro, Leu and Val residues, although no studies regarding the 202 
enzymatic action of Lactobacillus pentosus and Staphylococcus carnosus in dry-203 
fermented products have been reported. -Casein is also considered the best emulsifying 204 
agent among caseins as casein ability to lower the surface tension decreases from -205 
casein>1-casein>-casein (Dalgleish, 1997) so a higher proportion of this molecule 206 
could also explain the higher amount of identified sequences in comparison with the 207 
other caseins. 208 
On the other hand, the intense degradation of casein protein occurred when added as an 209 
additive in dry-fermented products will contribute not only to the characteristic flavor 210 
and aroma properties of these types of products but also to their bioactive activity.  In 211 
this sense, casein-derived peptides have been described to exert antihypertensive, 212 
immunoregulating, antithrombotic, antimicrobial, and opioid activities in fermented 213 
Formatted: Font color: Red
10 
 
milk products such as yogurt, sour milk, or kefir, being beneficial for the general health. 214 
Due to some studies using LAB have demonstrated their potential to generate bioactive 215 
peptides, some of the previously identified casein-derived bioactive sequences have 216 
been compared with the sequences identified in this study. Tables 2 and 3 show some 217 
examples of the peptides identified in this study sharing sequences with previously 218 
described bioactive peptides. In this sense and as an example, peptides YQEPLV, 219 
YQEPVLGPVR and YQEPVLGPVRGPFPI have been identified in the studied extract, 220 
and were previously described as ACE inhibitory peptides obtained from fragments of 221 
-casein protein. Similar sequences YQEPVLGPVRGPFPIIV and 222 
LLYQEPVLGPVRGPFPIIV have been also identified as antimicrobial (Sandre et al., 223 
2001) and immunoregulatory (Hayes et al., 2007), respectively, as it is shown in Table 224 
2. On the other hand, peptide YPVEPFTE identified in this study was described to 225 
display a selective potentiating activity on isolated guinea pig ileum for bradykinin, as 226 
well as showed in vitro ACE-inhibitory and opiate-like activity (Perpetuo et al., 2003). 227 
Finally, peptide KKYKVPQL identified in Table 3 has also been described as 228 
responsible for ACE-inhibitory activity in Manchego cheeses (Gómez-Ruiz et al., 229 
2002). 230 
Conclusion 231 
In this study, an intense proteolysis has been proved to occur during the dry-fermented 232 
processing. The obtained results are in agreement to those observed in dry-cured meat 233 
products due to the combined action of LAB and endogenous enzymes.  234 
The use of peptidomic analysis tools together with mass spectrometry in tandem allows 235 
the complex identification of those peptides released during the dry-fermented 236 
processing, helping in a better understanding of the proteolysis mechanisms as well as 237 
the influence of bacterial action in this type of meat products.  238 
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The action of LAB contributes to the generation of bioactive peptides, and the addition 239 
of sodium caseinate in dry-fermented sausages results on the formation of bioactive 240 
peptides that have been previously described as derived from milk products, influencing 241 
in the final peptides profile of this type of products. What is more, the optimised 242 
methodology might result very useful in the detection of fraudulent addition of casein 243 
protein by the identification of specific peptides generated during the dry-fermented 244 
processing. 245 
 246 
 247 
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FIGURE CAPTIONS 381 
Figure 1. MALDI-ToF spectra of the peptide extract of Spanish dry-fermented 382 
sausages. A) Values from 200 to 900 Da [M-H
+
] and B) Values from 850 to 3500 Da 383 
[M-H
+
]. 384 
Figure 2. Distribution of the peptides identified by nLC-MS/MS according to their 385 
protein of origin. 386 
Figure 3. Sequences of the four types of caseins obtained from UniProt database: -387 
casein (CASB_BOVIN; -S1-casein (CASA1_BOVIN); -S2-casein 388 
(CASA2_BOVIN); and -casein (CASK_BOVIN). 389 
Figure 4. Amino acids distribution for each type of casein protein calculated from their 390 
sequences. 391 
 392 
 393 
 394 
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 TABLES 
Table 1. Caseins identified by nLC-MS/MS from the peptides naturally generated 
during dry-fermented processing of Spanish sausages.  
Protein 
name Accession No.a No. Residues 
Sequence 
Cov. (%)b No. Peptidesc Ratiod 
-casein CASB_BOVIN 224 94 603 2.69 
-S1-casein CASA1_BOVIN 214 80 271 1.27 
-S2-casein CASA2_BOVIN 222 69 147 0.66 
-casein CASK_BOVIN 190 71 122 0.64 
a. Accession number in UniProt database (http://www.uniprot.org/). b. Percentage of sequence per 
protein identified by nLC-MS/MS. c. Total number of peptides identified in each protein with a 
confidence of 95%. d. Ratio numer of peptides vs number of residues. 
 
 
 
 
 
 
 
 
 
 
 
 
Table
 Table 2 
-Casein peptides identified by tandem mass spectrometry sharing sequences with 
previously described bioactive peptides. 
Accession No. Observed Calculated Mass
UniProt (m/z )
a (Da)
b
Charge P0 Identified sequence* Pf Sequence IC50 (mM) Activity References
CASB_BOVIN 748.40 747.39 1 L YQEPVL* G YQEPVL 280 ACE inhibitor Pihlanto-Leppala et al (1998), Meisel et al (2006)
717.45 1432.88 2 P IQAFLLYQEPVL G YQEP - antioxidative Silva, Pihlanto and Malcata (2006)
745.95 1489.89 2 P IQAFLLYQEPVLG P
579.32 1156.62 2 L YQEPVLGPVR* G YQEPVLGPVR 300 ACE inhibitor Meisel et al (2006)
607.85 1213.68 2 L YQEPVLGPVRG P YQEPVLGP - antioxidative Silva, Pihlanto and Malcata (2006)
656.35 1310.69 2 L YQEPVLGPVRGP F
729.90 1457.79 2 L YQEPVLGPVRGPF P
769.44 1536.87 2 F LLYQEPVLGPVRGP F
778.43 1554.84 2 L YQEPVLGPVRGPFP I VRGPFP - ACE inhibitor Gómez-Ruiz et al (2002)
834.93 1667.84 2 L LYQEPVLGPVRGPFP I
834.97 1667.93 2 L YQEPVLGPVRGPFPI* I YQEPVLGPVRGPFPI - ACE inhibitor Meisel and Schlimme (1994)
842.98 1683.94 2 F LLYQEPVLGPVRGPF P
891.48 1780.94 2 L YQEPVLGPVRGPFPII V
891.51 1781.00 2 F LLYQEPVLGPVRGPFP I
891.51 1781.01 2 L LYQEPVLGPVRGPFPI I
941.05 1880.09 2 L YQEPVLGPVRGPFPIIV* - YQEPVLGPVRGPFPIIV - antimicrobial Sandre et al (2001)
948.06 1894.10 2 F LLYQEPVLGPVRGPFPI I
948.06 1894.11 2 L LYQEPVLGPVRGPFPII V
997.58 1993.16 2 L LYQEPVLGPVRGPFPIIV - GPVRGPFPIIV - ACE inhibitor Nakamura et al (1995)
1004.60 2007.19 2 F LLYQEPVLGPVRGPFPII V
1054.13 2106.25 2 F LLYQEPVLGPVRGPFPIIV* - LLYQEPVLGPVRGPFPIIV - immunomodulating Hayes et al (2007)
1022.57 3064.70 3 Q RDMPIQAFLLYQEPVLGPVRGPFPIIV -
1064.60 3190.79 3 Y PQRDMPIQAFLLYQEPVLGPVRGPFPII V
776.41 1550.80 2 P FAQTQSLVYPFPGP I TQSLVYP 64 ACE inhibitor Kohmura, Nio and Ariyoshi (1990)
741.41 740.40 1 P FPGPIPN* S FPGPIPN 260 DPP IV inhibitor Ojeda, Cereto-Massagué, Valls and Pujadas (2014)
593.85 1185.68 2 Q SLVYPFPGPIP N PGPIPN - immunomodulating Meisel (1998)
650.87 1299.72 2 Q SLVYPFPGPIPN S SLVYPFPGPI - ACE inhibitor Hafeez et al (2014)
750.93 1499.85 2 Q SLVYPFPGPIPNSL P
799.45 1596.89 2 Q SLVYPFPGPIPNSLP Q
863.48 1724.95 2 Q SLVYPFPGPIPNSLPQ N
920.50 1838.99 2 Q SLVYPFPGPIPNSLPQN I
1074.10 2146.18 2 Q SLVYPFPGPIPNSLPQNIPP L
754.10 2259.29 3 Q SLVYPFPGPIPNSLPQNIPPL T
1181.17 2360.32 2 Q SLVYPFPGPIPNSLPQNIPPLT Q
830.47 2488.39 3 Q SLVYPFPGPIPNSLPQNIPPLTQ T
896.51 2686.51 3 Q SLVYPFPGPIPNSLPQNIPPLTQTP V
1060.28 3177.82 3 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPP F
1109.31 3324.91 3 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPF L
1147.01 3438.01 3 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFL Q
1189.69 3566.06 3 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQ P
916.79 3663.13 4 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQP E
949.05 3792.17 4 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPE V
973.82 3891.24 4 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEV M
1006.59 4022.32 4 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVM G
1020.84 4079.32 4 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVMG V
876.9823 1751.95 2 S LVYPFPGPIPNSLPQN* I LVYPFPGPIPNSLPQN 71 ACE inhibitor Pihlanto, Virtanen and Korhonen, (2010)
687.3968 2059.1684 3 S LVYPFPGPIPNSLPQNIPP* L LVYPFPGPIPNSLPQNIPP 5 ACE inhibitor Hernández-Ledesma, Quirós, Amigo, and Recio (2007)
438.76 875.50 2 H KEMPFPK Y EMPFPK - ACE inhibitor Pihlanto-Leppala et al (1998);Perpetuo et al (2003)
911.45 910.44 1 K EMPFPKY P
338.53 1012.56 3 K HKEMPFPK Y
520.28 1038.55 2 H KEMPFPKY P
588.81 1175.61 2 K HKEMPFPKY P
637.34 1272.66 2 K HKEMPFPKYP V
652.86 1303.70 2 P KHKEMPFPKY P
437.26 1308.76 3 M APKHKEMPFPK Y
467.93 1400.78 3 A PKHKEMPFPKY P
480.93 1439.78 3 A MAPKHKEMPFPK Y
736.90 1471.79 2 M APKHKEMPFPKY P
504.61 1510.82 3 E AMAPKHKEMPFPK Y
802.42 1602.83 2 A MAPKHKEMPFPKY P
837.94 1673.87 2 E AMAPKHKEMPFPKY P
601.98 1802.92 3 K EAMAPKHKEMPFPKY P
499.79 1995.12 4 S KVKEAMAPKHKEMPFPK Y VKEAMAPK antioxidant Suetsuna et al (2000); Korhonen and Pihlanto (2007)
1016.05 2030.08 2 K VKEAMAPKHKEMPFPKY P
1080.09 2158.17 2 S KVKEAMAPKHKEMPFPKY P
801.44 2401.29 3 M GVSKVKEAMAPKHKEMPFPKY P
565.53 2822.63 5 L QPEVMGVSKVKEAMAPKHKEMPFPK Y
960.80 3839.16 4 I PPLTQTPVVVPPFLQPEVMGVSKVKEAMAPKHKEM P
966.55 3862.17 4 V PPFLQPEVMGVSKVKEAMAPKHKEMPFPKYPVEP F
1006.59 4022.32 4 Q SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVM G
981.48 980.47 1 K YPVEPFTE* S YPVEPFTE - ACE inhibitor Perpetuo, Juliano and Lebrun (2003)
603.82 1205.63 2 F PKYPVEPFTE S - opioid Perpetuo et al (2003)
647.34 1292.67 2 F PKYPVEPFTES Q
754.88 1507.75 2 F PKYPVEPFTESQS L
935.48 1868.95 2 P FPKYPVEPFTESQSLT L
860.77 3439.04 4 E MPFPKYPVEPFTESQSLTLTDVENLHLPLP L
915.62 914.61 1 N LHLPLPLL Q LHLPLP 5 ACE inhibitor Hernández-Ledesma, Quirós, Amigo, and Recio (2007)
458.80 915.59 2 E NLHLPLPL L HLPLP ACE inhibitor
a. Relation of mass/charge observed in the nLC-MS/MS spectrophotometer expressed in m/z .
b. Calculated relative molecular mass of the matched peptide in Daltons.
c. Sequences and data of previously described bioactive peptides sharing same or part of the sequence with the casein-derived peptides identified in this study from dry-fermented sausages.
* Sequences identified in this study showing an asterisc indicates that the sequence has been previously described as bioactive. Bold residues are sequences showing bioactive properties.
Previously identified bioactive peptides
c
Table 3 
-S1-, -S2- and -Casein peptides identified by tandem mass spectrometry sharing 
sequences with previously described bioactive peptides. 
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A) From 200 to 900 m/z 
 
B) From 850 to 3500 m/z 
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Figure 2
       CASB_BOVIN 
     1 MKVLILACLV ALALARELEE LNVPGEIVES LSSSEESITR INKKIEKFQS  
    51 EEQQQTEDEL QDKIHPFAQT QSLVYPFPGP IPNSLPQNIP PLTQTPVVVP  
   101 PFLQPEVMGV SKVKEAMAPK HKEMPFPKYP VEPFTESQSL TLTDVENLHL  
   151 PLPLLQSWMH QPHQPLPPTV MFPPQSVLSL SQSKVLPVPQ KAVPYPQRDM  
   201 PIQAFLLYQE PVLGPVRGPF PIIV 
      CASA1_BOVIN 
     1 MKLLILTCLV AVALARPKHP IKHQGLPQEV LNENLLRFFV APFPEVFGKE  
    51 KVNELSKDIG SESTEDQAME DIKQMEAESI SSSEEIVPNS VEQKHIQKED  
   101 VPSERYLGYL EQLLRLKKYK VPQLEIVPNS AEERLHSMKE GIHAQQKEPM  
   151 IGVNQELAYF YPELFRQFYQ LDAYPSGAWY YVPLGTQYTD APSFSDIPNP  
   201 IGSENSEKTT MPLW 
      CASA2_BOVIN 
     1 MKFFIFTCLL AVALAKNTME HVSSSEESII SQETYKQEKN MAINPSKENL  
    51 CSTFCKEVVR NANEEEYSIG SSSEESAEVA TEEVKITVDD KHYQKALNEI  
   101 NQFYQKFPQY LQYLYQGPIV LNPWDQVKRN AVPITPTLNR EQLSTSEENS  
   151 KKTVDMESTE VFTKKTKLTE EEKNRLNFLK KISQRYQKFA LPQYLKTVYQ  
   201 HQKAMKPWIQ PKTKVIPYVR YL 
      CASK_BOVIN 
     1 MMKSFFLVVT ILALTLPFLG AQEQNQEQPI RCEKDERFFS DKIAKYIPIQ  
    51 YVLSRYPSYG LNYYQQKPVA LINNQFLPYP YYAKPAAVRS PAQILQWQVL  
   101 SNTVPAKSCQ AQPTTMARHP HPHLSFMAIP PKKNQDKTEI PTINTIASGE  
   151 PTSTPTTEAV ESTVATLEDS PEVIESPPEI NTVQVTSTAV  
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